law of increasing return

Digital

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

News

Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.